These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6235448)

  • 1. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
    Saxena RK; Saxena QB; Adler WH
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):34-42. PubMed ID: 6235448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
    Savary CA; Lotzová E
    J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine.
    Mowat AM; Tait RC; MacKenzie S; Davies MD; Parrott DM
    Clin Exp Immunol; 1983 Apr; 52(1):191-8. PubMed ID: 6222852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
    Miller SC; Christopher FL; Dussault I
    Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
    Pattengale PK; Ramstedt U; Gidlund M; Orn A; Axberg I; Wigzell H
    Eur J Immunol; 1983 Nov; 13(11):912-9. PubMed ID: 6641788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of low natural killer cell activity in 89Sr-treated mice.
    Mellen PF; Lust JA; Bennett M; Kumar V
    Eur J Immunol; 1982 May; 12(5):442-5. PubMed ID: 6212259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK activity in carrageenan-treated mice.
    Quan PC; Kolb JP; Lespinats G
    Immunology; 1980 Aug; 40(4):495-503. PubMed ID: 6159311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
    Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells.
    Harada M; Lin T; Kurosawa S; Maeda T; Umesue M; Itoh O; Matsuzaki G; Nomoto K
    Cell Immunol; 1995 Mar; 161(1):42-9. PubMed ID: 7867084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
    Herbert AG; Le Gros GS; Bidawid S; Watson JD
    Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
    Dussault I; Miller SC
    Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of spleen cells from mice treated with radioactive strontium: suppressor cells, natural killer cells, and "hybrid resistance" in recipient mice.
    Levy EM; Bennett M; Kumar V; Fitzgerald P; Cooperband SR
    J Immunol; 1980 Feb; 124(2):611-8. PubMed ID: 6444313
    [No Abstract]   [Full Text] [Related]  

  • 20. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.